Patient-Centered Outcomes Research (PCOR) helps people and their caregivers communicate and make informed health care decisions, allowing their voices to be heard in assessing the value of health care options. Comparative effectiveness research (CER) is designed to inform health-care decisions by providing evidence on the benefits and harms of different treatment options. The evidence is generated or synthesized from research studies that compare drugs, medical devices, or ways to deliver healthcare. This K24 award will extend the candidate's mentoring program that has allowed him to mentor 14 trainees and junior faculty during the prior cycle. Few clinical researchers in rheumatology are well trained to pursue PCOR or CER. Funding opportunities in these areas are likely to be 1 of few areas of growth in the federal research budget.
The aims noted below will create an innovative set of databases ideal for PCOR and CER and will pursue CER studies with clinical relevance that provide excellent training opportunities. 1. To link an administrative claims database with an electronic medical record (EMR) database for three different rheumatic disease cohorts -- rheumatoid arthritis (RA), osteoarthritis (OA), and gout -- and then examine the agreement between databases. EMR databases have unique strengths and weaknesses that complement the strengths and weaknesses of administrative claims databases. There have been almost no prior attempts to link these two types of databases. We have already received approvals for the linkage, and data are currently being processed. Both databases share a unique identifier, allowing a deterministic linkage. We will assess 4 types of agreement in each cohort: agreement in underlying diagnosis, relevant drug exposures, covariates, and outcomes. 2. To conduct patient-centered outcomes research using the linked databases for these three cohorts. After linking the databases, we will conduct distinct patient-centered outcomes studies.
In Aim 2 a, we will examine the risk of fractures associated with oral glucocorticoids in RA. There have not been similar comparative effectiveness studies assessing whether patients with similar bone mineral density who use oral glucocorticoids are more likely to sustain fragility fractures.
I Aim 2 b, we will examine the role of TJR on all- cause mortality in moderate-severe hip and knee OA. TJR has clear short-term beneficial effects on pain and function, but it may also have long-term benefits, as has been suggested by at least one prior study. Prior work has had substantial limitations that can be overcome by the proposed linked database. Finally, Aim 2c will investigate the potential role of UALT on CVD outcomes. Strong epidemiologic data link hyperuricemia with CVD, but there have been no large studies examining whether treatments such as allopurinol, febuxostat, probenecid, or pegloticase may play a role in reducing CVD.

Public Health Relevance

Patient-Centered Outcomes Research (PCOR) helps people and their caregivers communicate and make informed health care decisions, allowing their voices to be heard in assessing the value of health care options. Comparative effectiveness research (CER) is designed to inform health-care decisions by providing evidence on the benefits and harms of different treatment options. The evidence is generated or synthesized from research studies that compare drugs, medical devices, or ways to deliver healthcare. This K24 award will extend the candidate's mentoring program that has allowed him to mentor 14 trainees and junior faculty during the prior cycle, focusing on PCOR and CER in rheumatology.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Midcareer Investigator Award in Patient-Oriented Research (K24)
Project #
2K24AR055989-06
Application #
8562436
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Program Officer
Witter, James
Project Start
2008-05-08
Project End
2018-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
6
Fiscal Year
2013
Total Cost
$145,700
Indirect Cost
$10,793
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Feldman, Candace H; Costenbader, Karen H; Solomon, Daniel H et al. (2018) Area-level Predictors of Medication Nonadherence among U.S. Medicaid Beneficiaries with Lupus: A Multilevel Study. Arthritis Care Res (Hoboken) :
Barbhaiya, Medha; Feldman, Candace H; Guan, Hongshu et al. (2018) Racial/ethnic variation in stroke rates and risks among patients with systemic lupus erythematosus. Semin Arthritis Rheum :
Tedeschi, Sara K; Solomon, Daniel H; Liao, Katherine P (2018) Pseudogout among Patients Fulfilling a Billing Code Algorithm for Calcium Pyrophosphate Deposition Disease. Rheumatol Int 38:1083-1088
Feldman, Candace H; Collins, Jamie; Zhang, Zhi et al. (2018) Dynamic patterns and predictors of hydroxychloroquine nonadherence among Medicaid beneficiaries with systemic lupus erythematosus. Semin Arthritis Rheum 48:205-213
Yoshida, Kazuki; Yu, Zhi; Greendale, Gail A et al. (2018) Effects of analgesics on bone mineral density: A longitudinal analysis of the prospective SWAN cohort with three-group matching weights. Pharmacoepidemiol Drug Saf 27:182-190
Yu, Zhi; Yang, Nicole; Everett, Brendan M et al. (2018) Impact of Changes in Inflammation on Estimated Ten-Year Cardiovascular Risk in Rheumatoid Arthritis. Arthritis Rheumatol 70:1392-1398
Hresko, Andrew; Lin, Tzu-Chieh; Solomon, Daniel H (2018) Medical Care Costs Associated With Rheumatoid Arthritis in the US: A Systematic Literature Review and Meta-Analysis. Arthritis Care Res (Hoboken) 70:1431-1438
Solomon, Daniel H; Lu, Bing; Yu, Zhi et al. (2018) Benefits and Sustainability of a Learning Collaborative for Implementation of Treat-to-Target in Rheumatoid Arthritis: Results of a Cluster-Randomized Controlled Phase II Clinical Trial. Arthritis Care Res (Hoboken) 70:1551-1556
Lee, Moa P; Lii, Joyce; Jin, Yinzhu et al. (2018) Patterns of Systemic Treatment for Psoriatic Arthritis in the US: 2004-2015. Arthritis Care Res (Hoboken) 70:791-796
Zhang, MaryAnn; Solomon, Daniel H; Desai, Rishi J et al. (2018) Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol. Circulation 138:1116-1126

Showing the most recent 10 out of 161 publications